Cassava Sciences (SAVA) Earnings Date, Estimates & Call Transcripts $2.61 -0.12 (-4.40%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cassava Sciences Latest Earnings SummaryActual EPS (Nov. 7) -$0.58 Beat By $0.79 Consensus EPS (Nov. 7) -$1.37 Cassava Sciences issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.58, which topped analysts' consensus estimates of -$1.37 by $0.79. With a trailing EPS of -$1.38, Cassava Sciences' earnings are expected to grow next year, from ($3.97) to ($0.62) per share. Conference CallConference Call Transcript Get Cassava Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cassava Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSAVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SAVA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Cassava Sciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($3.97) EPSNext Year EPS Consensus Estimate: ($0.62) EPS Cassava Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/7/2024Q3 2024-$1.37-$0.58+$0.79-$0.58--8/8/2024Q2 2024-$0.44$0.13+$0.57-$2.69--5/10/2024Q1 2024-$0.51-$1.41 -$0.90-$2.39--2/28/2024Q4 2023-$0.40-$0.50 -$0.10-$0.50--11/7/2023Q3 2023-$0.6429-$0.4357+$0.2071-$0.61--8/3/2023Q2 2023-$0.4143-$0.45 -$0.0357-$0.63-- Get the Latest News and Ratings for SAVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter. 5/1/2023Q1 2023-$0.40-$0.4143 -$0.0143-$0.58--2/28/2023Q4 2022-$0.4143-$0.3357+$0.0786-$0.47-- Cassava Sciences Earnings - Frequently Asked Questions When did Cassava Sciences announce their last quarterly earnings? Cassava Sciences (NASDAQ:SAVA) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on SAVA's earnings history. Did Cassava Sciences beat their earnings estimates last quarter? In the previous quarter, Cassava Sciences (NASDAQ:SAVA) reported ($0.58) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.37) by $0.79. Learn more on analysts' earnings estimate vs. SAVA's actual earnings. How can I listen to Cassava Sciences's earnings conference call? The conference call for Cassava Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Cassava Sciences's conference call transcript? The conference call transcript for Cassava Sciences's latest earnings report can be read online. Read Transcript How much profit does Cassava Sciences generate each year? Cassava Sciences (NASDAQ:SAVA) has a recorded net income of -$97.22 million. SAVA has generated -$1.38 earnings per share over the last four quarters. What is Cassava Sciences's EPS forecast for next year? Cassava Sciences's earnings are expected to grow from ($3.97) per share to ($0.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies Mereo BioPharma Group Earnings Rapport Therapeutics Earnings Ginkgo Bioworks Earnings Entrada Therapeutics Earnings Oruka Therapeutics Earnings Xeris Biopharma Earnings Tourmaline Bio Earnings Altimmune Earnings Mind Medicine (MindMed) Earnings Stoke Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:SAVA) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
